文献速递神经肿瘤

海绵窦脑膜瘤减压手术的结局:50例患者长期随访

Outcomes of decompressive surgery for cavernous sinus meningiomas: long-term follow-up in 50 patients.
PubMed 文献 · J Neurosurg · 2019-02-15

该回顾性分析纳入2002—2017年50例海绵窦脑膜瘤患者,采用额颞开颅行次全切除并同期减压海绵窦顶壁、外侧壁及同侧视神经,25例(50%)术后辅助放疗。术前颅神经病变52%改善、46%稳定、2%加重;术前视觉障碍97%改善或稳定;10例出现12处新发颅神经障碍,其中半数为一过性并最终缓解;影像学复发5例(10%),中位复发时间4.6年。作者认为手术减压联合或不联合辅助放疗是有效的肿瘤学策略,肿瘤控制率良好且神经并发症风险低。

要点

  • 50例海绵窦脑膜瘤行次全切除联合海绵窦及视神经减压,25例(50%)接受辅助放疗。
  • 术前颅神经病变术后52%改善、46%稳定、2%加重;术前视觉障碍97%改善或稳定。
  • 10例出现12处新发颅神经障碍,半数一过性并最终缓解;影像学复发5例(10%)。

核心结论

  • 作者认为,采用手术减压联合或不联合辅助放疗治疗海绵窦脑膜瘤是有效的肿瘤学策略,肿瘤控制率良好且神经并发症风险低。

研究设计与样本

  • 回顾性分析2002—2017年15年间接受该策略治疗的海绵窦脑膜瘤患者,共识别50例,均行额颞开颅次全切除并同期减压海绵窦及同侧视神经。

主要发现

  • 50例中25例(50%)对海绵窦内残留肿瘤行辅助放疗。
  • 患者最常见表现为累及CN III–VI的颅神经麻痹(70%)、视觉障碍(62%)、头痛(52%)或突眼(44%)。
  • 35例术前存在颅神经障碍,术后52%改善、46%稳定、仅2%加重。
  • 术前视觉障碍97%术后改善或稳定。
  • 10例患者术后出现12处新发颅神经障碍,其中半数为一过性并最终缓解;影像学复发5例(10%),中位复发时间4.6年。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Cavernous sinus meningiomas are complex tumors that offer a perpetual challenge to skull base surgeons. The senior author has employed a management strategy for these lesions aimed at maximizing tumor control while minimizing neurological morbidity. This approach emphasizes combining "safe" tumor resection and direct decompression of the roof and lateral wall of the cavernous sinus as well as the optic nerve. Here, the authors review their experience with the application of this technique for the management of cavernous sinus meningiomas over the past 15 years. METHODS: A retrospective analysis was performed for patients with cavernous sinus meningiomas treated over a 15-year period (2002-2017) with this approach. Patient outcomes, including cranial nerve function, tumor control, and surgical complications were recorded. RESULTS: The authors identified 50 patients who underwent subtotal resection via frontotemporal craniotomy concurrently with decompression of the cavernous sinus and ipsilateral optic nerve. Of these, 25 (50%) underwent adjuvant radiation to the remaining tumor within the cavernous sinus. Patients most commonly presented with a cranial nerve (CN) palsy involving CN III-VI (70%), a visual deficit (62%), headaches (52%), or proptosis (44%). Thirty-five patients had cranial nerve deficits preoperatively. In 52% of these cases, the neuropathy improved postoperatively; it remained stable in 46%; and it worsened in only 2%. Similarly, 97% of preoperative visual deficits either improved or were stable postoperatively. Notably, 12 new cranial nerve deficits occurred postoperatively in 10 patients. Of these, half were transient and ultimately resolved. Finally, radiographic recurrence was noted in 5 patients (10%), with a median time to recurrence of 4.6 years. CONCLUSIONS: The treatment of cavernous sinus meningiomas using surgical decompression with or without adjuvant radiation is an effective oncological strategy, achieving excellent tumor control rates with low risk of neurological morbidity.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Gozal YM, Alzhrani G, Abou-Al-Shaar H, et al. Outcomes of decompressive surgery for cavernous sinus meningiomas: long-term follow-up in 50 patients. J Neurosurg. 2019. PMID: 30771770. doi:10.3171/2018.10.JNS181480

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。